Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
Nest Genomics develops genomics solutions to integrate genetic testing into routine patient care. The company is led by former Clear Genetics founders and employs genetic counselors and engineers.
6 investors
Notable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
6 investors
Openwater develops an imaging platform using two optical modalities designed to diagnose and monitor diseases at the size and cost of a smartphone. The platform combines hardware, software, and open-source designs for use in clinical settings at hospitals, research institutions, and government programs worldwide, with trials spanning cancer, neurological disease, mental health, and metabolic conditions.
6 investors
Orange Health Labs operates a home-based diagnostic testing service in Indian cities, offering sample collection within 30 minutes and lab results within 6 hours. The company serves urban consumers seeking rapid medical testing across major metropolitan areas.
6 investors
Orca Bio develops allogeneic T-cell immunotherapies for high-risk blood cancers including acute myeloid leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome. The company is advancing precision cell therapy treatments for patients with blood cancers and autoimmune diseases.
6 investors
Overjet builds AI software to assist dental providers with diagnosis and treatment planning. The platform serves dental practices, insurance payers, and patients to improve consistency and precision in oral healthcare delivery.
6 investors
Pear Bio delivers precision medicine tests and therapeutics for patients with hard-to-treat cancers by creating personalized treatment predictions from tumor biopsies and developing novel targeted therapies.
6 investors
Perfuse Therapeutics is a biotechnology company developing a therapy to improve blood flow to the retina, targeting ocular diseases such as glaucoma and diabetic retinopathy. The company aims to reduce blindness caused by these conditions.
6 investors
Persist AI provides AI-driven formulation development services for pharmaceutical compounds, combining robotic lab automation with machine learning models to accelerate drug formulation optimization and reduce time-to-market.
6 investors
Positive Development provides autism therapy and developmental care services for neurodivergent children and their families. The company delivers evidence-based care through a multidisciplinary team approach focused on supporting both the child and whole family.
6 investors
PulseMedica develops femtosecond laser technology for imaging and treating vitreoretinal eye conditions, building medical devices aimed at improving care for patients with retinal diseases. The company operates in the ophthalmic medical device sector.
6 investors
QurAlis develops precision therapies for amyotrophic lateral sclerosis (ALS) and related neurodegenerative diseases by targeting specific disease-causing genetic drivers and molecular mechanisms. The company was founded by neuroscientists from Harvard to translate emerging discoveries about disease pathways into treatment breakthroughs for ALS patients.
6 investors
Raydiant Oximetry is a clinical-stage medical device company developing Lumerah, a noninvasive fetal pulse oximeter that directly measures fetal oxygen levels using biophotonics and machine learning. The device is intended to give obstetrical providers a more accurate tool for evaluating fetal oxygenation during labor and delivery.
6 investors
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease. The technology is used by cancer treatment centers, including freestanding cancer centers and hospital outpatient departments, to treat solid tumors at any stage.
6 investors
Medtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
6 investors
Sanity Group manufactures and distributes cannabinoid-based pharmaceutical products under the avaay Medical brand across European markets, including medical cannabis. The company operates in the medical cannabis and pharmaceutical sector, with a focus on patient access to cannabis-based therapeutics.
6 investors
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases. The company focuses on novel therapeutic approaches for patients with rare respiratory conditions.
6 investors
Sorcero develops AI-powered intelligence solutions for the life sciences industry, helping companies accelerate patient access to therapies and improve medical research and communications. The platform uses medically-tuned large language models to support pharmaceutical, biotech, and healthcare organizations.
6 investors
STORM Therapeutics is a clinical-stage biotechnology company developing small molecule drugs that target RNA modifying enzymes to reprogram cells through RNA biology. Its therapies address cancer, inflammation, viral infections, and CNS diseases.
6 investors
Strados Labs builds wearable biosensors and a cloud platform that continuously capture and analyze respiratory data — including cough, spirometry, FeNO, and eCOA endpoints — in patients' daily lives. It combines AI detection with review by credentialed respiratory specialists to produce regulatory-grade, audit-ready evidence for pharma sponsors running decentralized clinical trials.
6 investors
Strolll offers an augmented reality platform for neurological rehabilitation, providing gait training, rehab exercises, and assessments in one system. It is designed for clinicians and patients across inpatient, outpatient, and home care settings.
6 investors
Switch Therapeutics develops RNA interference (RNAi) therapeutic applications targeting central nervous system diseases, leveraging research from Caltech, Harvard Medical School, and City of Hope.
6 investors
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases. The company applies synthetic biology approaches to design programmable therapeutic candidates for patients.
6 investors
Syntax Bio develops a discovery platform that accelerates stem cell-derived therapies by using its proprietary Cellgorithm technology to control and direct cell differentiation. The platform enables biopharma companies to speed up cell therapy development, reduce manufacturing costs, and expand their pipeline of potential treatments.
6 investors